Alma AI

Curated by Signal

AI-driven drug discovery platform for neurological disorders

Overview

AI-driven drug discovery platform for neurological disorders. It revolutionizing drug design for neurological disorders by integrating deep learning architectures and physics-score-based modeling.

Key facts

Founded: 2023
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Business model

7 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

CHI St. Joseph
Provider of teleconsultation platform for patients
Health TechnologyBryan, United States
Healthline Media
Online information platform offering health and wellness topics
Health TechnologyNew York City, United States
Conduce Health
Platform offering multi specialty value based care marketplace
Health TechnologyNew York City, United States

About Alma AI

What does Alma AI do?

AI-driven drug discovery platform for neurological disorders.

Where is Alma AI headquartered?

Alma AI is headquartered in New York City, United States.

When was Alma AI founded?

Alma AI was founded in 2023.

Which sector is Alma AI in?

Alma AI operates in Health Technology.

Who are Alma AI's competitors?

Companies similar to Alma AI include CHI St. Joseph, Healthline Media, and Conduce Health.